This article reviews antiviral therapies that have been approved for human use during the last decade, with a focus on the process chemistry that enabled access to these important drugs. In particular, process chemistry highlights from the practical syntheses of the HCV drugs sofosbuvir (Gilead), grazoprevir (Merck), and elbasvir (Merck), the HIV therapy darunavir (Tibotec) and the influenza treatment peramivir (BioCryst) are presented.
Keywords: Antivirals; Asymmetric synthesis; Darunavir; Elbasvir; Grazoprevir; HCV; HIV; Influenza; Peramivir; Practical synthesis; Process chemistry; Sofosbuvir.